Table 2.
Predictive statistics of 10-year risk prediction models
Continuous NRI | Categorical NRI (25% predicted risk cut-point) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||
C-statistic (95% CI) |
Difference in C- statistic (95% CI) |
P-value for difference |
Overall NRI (95% CI)* |
Event NRI (95% CI)* |
Non-event NRI (95% CI)* |
Overall NRI (95% CI)* |
Event NRI (95% CI)* |
Non-event NRI (95% CI)* |
Relative IDI (95% CI)* |
|
|
||||||||||
Model 1 (Self- reported) | 0.667 (0.64, 0.70) | -- | -- | -- | -- | -- | -- | |||
Model 2 (+ clinical variables) | 0.683 (0.65, 0.71) | 0.016† (0.00, 0.03) | 0.032† | 0.42† (0.26, 0.56) | 0.18† (0.07, 0.29) | 0.23† (0.13, 0.34) | 0.07† (0.03, 0.12) | -0.02† (−0.04, 0.00) | 0.09† (0.06, 0.14) | 0.28† (0.21, 0.36) |
Model 3 (+ HbA1c) | 0.694 (0.66, 0.72) | 0.011‡ (0.00, 0.02) | 0.021‡ | 0.25‡ (0.11, 0.40) | −0.02‡ (−0.13, 0.10) | 0.27‡ (0.17, 0.37) | 0.02‡ (−0.01, 0.06) | 0.01‡ (−0.01, 0.03) | 0.02‡ (−0.01, 0.05) | 0.08‡ (0.04, 0.11) |
Model 4 (+ additional biomarkers) | 0.716 (0.69, 0.74) | 0.022§ (0.01, 0.04) | 0.003§ | 0.32§ (0.17, 0.47) | 0.14§ (0.04, 0.25) | 0.18§ (0.07, 0.29) | 0.03§ (−0.02, 0.07) | −0.03§ (−0.06, −0.01) | 0.06§ (0.02, 0.09) | 0.15§ (0.09, 0.22) |
Bias-corrected 95% CIs are reported for NRI and IDI,and were obtained usingbootstrap with 1,000replications
vs. Model 1
vs. Model 2
vs. Model 3
Model 1 includes age, sex, race, education, smoking status, alcohol consumption, physical activity, family history of CVD, glucose-lowering medication use, antihypertensive medication use, cholesterol-lowering medication use, recent onset of diabetes, BMI, interaction of sex with glucose-lowering medication use, and interaction of race with BMI.
Model 2 additionally includes LDL-c, HDL-c, triglycerides, systolic blood pressure, interaction of sex with triglycerides, and interaction of race with triglycerides.
Model 3 additionally includes HbA1c.
Model 4 additionally includes 1/B2M, eGFR-Cr, and eGFR-CysC.